Increased Demand Drives Queensland Compound Library Expansion
News Jun 30, 2009
Queensland Compound Library (QCL) has announced the acquisition and installment of a third comPOUND® sample store from TTP LabTech Ltd. The purchasing of a third sample store, to integrate with their two existing comPOUND® sample stores and comPANION unit, comes a year after QCL became operational.
The new purchase reflects the success of QCL and the increased demand for compound management and logistics services now considered essential by Australian academia, medical research institutes, publicly funded research organizations and industry.
TTP LabTech’s comPOUND® sample store is a modular system, where stores can be linked in parallel. The self-contained modules can provide sample storage from ambient temperature down to -20° C depending on the user’s requirements. Sample tubes can be cherry picked from all linked stores, thereby allowing throughputs to increase as the library grows.
The comPANION unit connects comPOUND® stores to remote delivery or storage of individual microtubes from an expandable sample library. The QCL is said to be the only dedicated automated compound management facility for tube and plate based systems in Australasia and was the first facility of its kind world-wide to fully integrate modular storage and liquid handling platforms.
It is a national resource that services a range of organizations in the region and all of the comPOUND stores are run at a nominal temperature of 18° C. The QCL’s third comPOUND® is a component of the Queensland Tropical Health Alliance, a collaboration between Griffith University, James Cook University, the Queensland Institute of Medical Research and the QLD State Government.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug CandidateNews
Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.READ MORE